Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our September issue of Pharmaceutical Executive
FEATURES

Executive Profile
Paul Perreault, CSL: The Global CEO
 Julian Upton
CSL Limited's top executive talks about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.
ADVERTISEMENT
A panel discussion with insights from emerging biopharma executives
Wednesday, October 3, 2018 at 11am EDT
Register Now
Specialty Pharma Focus
Specialty Pharma's Move to Mainstream
 Michelle Maskaly
While definitions for "specialty drug" vary—and distribution and pricing/reimbursement factors remain complicated—this once-niche treatment market may be poised to steer the future of prescription medicine and patient care.
ADVERTISEMENT
Leverage Your Data to Meet Rising Expectations within Life Sciences
Thursday, September 13, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Specialty Pharma Focus
Beyond Big Data: Meeting the Specialty Marketing Challenge
 Julian Upton
With specialty companies getting smarter in applying their big data insights to product marketing, the true commercial potential of machine learning and predictive modeling may soon be within reach.
Specialty Pharma Focus
 The 'Spare-No Expense'-Alternative
 Charlie Bell
How low-cost drugs can succeed in the specialty pharmacy channel.
Specialty Pharma Focus
 Tackling Rare Mutation in CF
 Michelle Maskaly
How one nonprofit and its out-front leader are joining forces with industry to advance a new personalized medicine approach for cystic fibrosis patients nonsense mutations.

ALSO IN THIS ISSUE

Specialty Supply Chain Decisions
Lisa Henderson
In today's drug development environment, there is no doubt that supply chain decisions are paramount in a product launch strategy …Read more

FDA Struggles to Advance Biosimilars
Jill Wechsler
New Action Plan aims to streamline development, but rebates and reimbursement block market access …Read more

Design Thinking in Pharma
Adam Taicher
How industry can benefit from this new view on innovation …Read more
 
WEBCASTS
Commercializing on Your Own: A Panel Discussion with Insights from Emerging Biopharma Executives
Leverage Your Data to Meet Rising Expectations within Life Sciences
A Framework for Successful Biopharma Launches Understanding the launch Archetype and Identifying Critical Success Factors
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
Combination Therapies in Oncology: The Benefits of Integrated Insights
Patient Engagement in Clinical Trials
Capturing the attention of investors: How to create a compelling value story
HCP Multichannel Marketing – What Does Great Look Like?
 
Download the
issue:
 
image
 
 

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn